Form 8-K - Current report:
SEC Accession No. 0001193125-16-678199
Filing Date
2016-08-10
Accepted
2016-08-10 17:03:02
Documents
4
Period of Report
2016-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d236239d8k.htm 8-K 16779
2 EX-10.1 d236239dex101.htm EX-10.1 169084
3 EX-99.1 d236239dex991.htm EX-99.1 8059
4 GRAPHIC g236239g87k65.jpg GRAPHIC 9973
  Complete submission text file 0001193125-16-678199.txt   209360
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-21898 | Film No.: 161822179
SIC: 8731 Services-Commercial Physical & Biological Research